These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 3394965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ligated renal pedicles and duration of action of neostigmine and pyridostigmine.
    Miller RD, Roderick L.
    Br J Pharmacol; 1977 Aug; 60(4):555-8. PubMed ID: 907868
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antagonism of Org NC 45 neuromuscular blockade by neostigmine, pyridostigmine, and 4-aminopyridine.
    Booij LH, van der Pol F, Crul JF, Miller RD.
    Anesth Analg; 1980 Jan; 59(1):31-4. PubMed ID: 7188663
    [Abstract] [Full Text] [Related]

  • 8. The effect of temperature on a d-tubocurarine neuromuscular blockade and its antagonism by neostigmine.
    Miller RD, Van Nyhis LS, Eger EI.
    J Pharmacol Exp Ther; 1975 Nov; 195(2):237-41. PubMed ID: 1185593
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects on muscarinic receptors of various agents in reversal of neuro-muscular blockade: a study evaluating atropine, glycopyrron, neostigmine and pyridostigmine.
    Eriksen S, Hansen EK, Hasselstrøm L.
    Acta Anaesthesiol Scand; 1978 Nov; 22(4):447-57. PubMed ID: 726861
    [Abstract] [Full Text] [Related]

  • 14. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR, Kern S, Ficke DJ, Ebert TJ.
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [Abstract] [Full Text] [Related]

  • 15. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB.
    Anesth Analg; 1975 Mar; 54(3):317-21. PubMed ID: 1169015
    [Abstract] [Full Text] [Related]

  • 16. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O, White PF, Tufanogullari B, Klein K.
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [Abstract] [Full Text] [Related]

  • 17. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties.
    Pascuzzo GJ, Akaike A, Maleque MA, Shaw KP, Aronstam RS, Rickett DL, Albuquerque EX.
    Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955
    [Abstract] [Full Text] [Related]

  • 18. Antagonism of d-tubocurarine-induced neuromuscular blockade with a mixture of 4-aminopyridine and neostigmine in man.
    Wirtavuori K, Salmenperä M, Tammisto T.
    Can Anaesth Soc J; 1984 Nov; 31(6):624-30. PubMed ID: 6093961
    [Abstract] [Full Text] [Related]

  • 19. The effect of neostigmine on pyridostigmine bioavailability in myasthenic patients after oral administration.
    Chan K, Davison SC, Dehghan A, Hyman N.
    Methods Find Exp Clin Pharmacol; 1981 Nov; 3(5):291-6. PubMed ID: 7329157
    [Abstract] [Full Text] [Related]

  • 20. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy.
    Muenster T, Forst J, Goerlitz P, Schmitt HJ.
    Paediatr Anaesth; 2008 Mar; 18(3):251-5. PubMed ID: 18230069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.